Opendata, web and dolomites

TherGelFas SIGNED

Novel nanometrically structured therapeutic hydrogel as injectable for fascial tissues surrounding the nerves intended for preventive treatment of chronic pain

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TherGelFas project word cloud

Explore the words cloud of the TherGelFas project. It provides you a very rough idea of what is the project "TherGelFas" about.

prepare    fascial    original    thereby    biodegradable    perform    researcher    create    steroidal    blockade    scalable    acute    business    peripheral    fast    treatment    biocompatible    tissue    critical    materials    antiinflamatory    release    operative    hydrogels    unsuccessful    training    times    documentation    goals    of    achievement    strategies    stages    multimodal    porous    originates    talented    chronifies    pain    prevention    chronification    expertise    protects    innovative    load    polymer    nerves    surgery    expects    improvement    agencies    manufacturing    medicinal    marketing    scientifically    proof    thergelfas    host    regulatory    post    correctly    hydrogel    first    launch    chronic    replace    unfortunately    efficient    nanostructured    nerve    scientific    combining    therapies    medical    acid    made    record    therapeutically    injectable    antiseptic    hyaluronic    carrier    biomaterials    injections    corresponding    drugs    manner    prevent   

Project "TherGelFas" data sheet

The following table provides information about the project.

Coordinator
I+MED S.COOP. PEQUENA 

Organization address
address: CALLE ALBERT EINSTEIN 15
city: VITORIA-GASTEIZ
postcode: 1510
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 170˙121 €
 EC max contribution 170˙121 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2020-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    I+MED S.COOP. PEQUENA ES (VITORIA-GASTEIZ) coordinator 170˙121.00

Map

 Project objective

The key goals of the “TherGeLFas” project are: (a) the training of a talented experienced researcher in the fast growing field of innovative biomaterials for medical applications where the host and partner institutions have a critical knowledge and expertise; and, (b) the design and development of cost- efficient polymer materials in order to develop a new medicinal product for post-operative acute pain treatment and prevention of chronification. The aim of the research project and the main scientific challenge is thereby to develop a ‘therapeutically effective’ hydrogel based injectable product to be applied during and post-surgery in the fascial tissue that protects the nerves where the pain originates and chronifies. TherGelFas expects to create the proof of concept of a new medicinal product by combining advanced materials (a biodegradable, antiseptic and biocompatible carrier, made of porous nanostructured hydrogel based on hyaluronic acid) with the ability to load and release non-steroidal antiinflamatory drugs in a controlled manner. It is aimed for the improvement of the current multimodal strategies of peripheral nerve blockade injections used during and post-surgery in acute pain treatment to prevent it from becoming chronic and that unfortunately are unsuccessful many times. The first achievement will be that of the training of the experienced researcher in new areas of knowledge such as business development from original concept stages to production scale-up, manufacturing and marketing stages. The second achievement will be to scientifically assess whether these hydrogels can improve and replace currently used therapies, to develop a proof-of-concept scalable product. The third achievement will be to learn how to perform correctly the necessary steps needed to launch a product of this kind, such as record and prepare all the documentation needed to present the product to the corresponding regulatory agencies.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "THERGELFAS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "THERGELFAS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

NeoPur (2019)

New treatments and novel diagnostic tests for neonatal seizures based on purinergic signaling.

Read More  

MathematicsAnalogies (2019)

Mathematics Analogies

Read More  

PNAIC (2018)

Positive and Negative Asymmetry in Intergroup Contact: Its Impact on Linguistic Forms of Communication and Physiological Responses

Read More